Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation).

Current atherosclerosis reports - 1 Aug 2011

Easton J Donald

Abstract excerpt

The new definition and risk stratification for transient ischemic attack (TIA) have clear implications for the urgency of evaluation and treatment. The optimal antithrombotic treatment for TIA is being intensively studied. New guidelines for prevention of non-cardioembolic stroke in patients with stroke or TIA recommend the use of antiplatelet agents rather than oral anticoagulation. New antiplatelet drugs are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to Fibrinolytic Agents
Share to Ischemic Attack, Transient

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prasugrel Hydrochloride

Share to Tetrazoles

Share to Thiophenes

Share to Ticagrelor

Share to Ticlopidine

Source

Identifiers

PMID: 21584696
DOI: 10.1007/s11883-011-0185-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation).PMID 21584696Read ↗

Recent advances in the understanding and management of atrial fibrillation: a focus on stroke preventionSemantic proximity Read ↗

Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial.Semantic proximity Read ↗

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.Semantic proximity Read ↗

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.Semantic proximity Read ↗

Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndrome.Semantic proximity Read ↗

Patent foramen ovale, stroke, and cardiovascular disease in migraine.Semantic proximity Read ↗

Ischemic stroke and patent foramen ovale: risk factors and genetic profile.Semantic proximity Read ↗

Atrial fibrillation: modern concepts and management.Semantic proximity Read ↗

CYP2C19 genotype-guided antiplatelet therapy to prevent thromboembolic events after stent-assisted coil embolization of unruptured intracranial aneurysms: a retrospective cohort study.Semantic proximity Read ↗

Reperfusion thrombolytic therapy for ischemic stroke in patients on non-vitamin K antagonist oral anticoagulants: study protocol of a phase II randomized clinical trialSemantic proximity Read ↗

Hypercoagulability and Migraine.Semantic proximity Read ↗

A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.